Journal Guide

Natural Product Reports (NPR) is a critical review journal that stimulates progress in all areas of natural products research, including isolation, structural and stereochemical determination, biosynthesis, biological activity and synthesis. Natural Product Reports covers natural products from marine, plant, fungal and microbial environments. The scope of the journal is very broad, and many reviews discuss the role of natural products in the wider bioinorganic, bioorganic and chemical biology communities. Areas covered include the following: Total synthesis and semi-synthesis; Enzymology and structural biology; Biosynthesis and biotechnology; Nucleic acids; Genetics; Chemical ecology; Carbohydrates; Primary and secondary metabolism; Analytical techniques

The Natural Products Journal publishes original research articles, reviews, letters and guest edited issues on all aspects of research and development in the field including: isolation, purification, structure elucidation, synthesis and bioactivity of chemical compounds found in nature.

Nature Reviews Drug Discovery is a monthly journal aimed at everyone working in the drug discovery and development arena. In addition to the highest-quality reviews and perspectives covering the entire field, each issue includes news stories that investigate the hottest topics in drug discovery, timely summaries of key primary research papers, and concise updates on the latest advances in fast-moving areas such as new drug approvals, patent law and emerging industry trends.Subjects covered * Target discovery * Rational drug design * Combinatorial and parallel synthesis * Medicinal chemistry * Key compound classes * Natural products * High-throughput screening * Novel therapeutic approaches to disease states * Microarrays * Bioinformatics and chemoinformatics * Absorption, distribution, metabolism and elimination (ADME) * Pharmacokinetics and pharmacodynamics * Pharmacology * Toxicology * Pharmacogenomics and toxicogenomics * Drug delivery * Biopharmaceuticals * Biotechnology * Vaccines * Clinical trial evaluation * Regulatory issues * Pharmacoeconomics.

Founded in 1873, Naunyn-Schmiedeberg's Archives of Pharmacology is edited on behalf of the German Society of Experimental and Clinical Pharmacology and Toxicology (DGPT), and the Sphingolipid Club. This monthly journal publishes invited reviews, original articles and short communications. Coverage focuses on new and significant information on drug action and toxicity of chemical compounds. Thus, its scope extends to all fields of experimental and clinical pharmacology as well as toxicology and includes studies in the fields of neuropharmacology and cardiovascular pharmacology as well as those describing drug actions at the cellular, biochemical and molecular levels. Short communications offer rapid publication of significant findings of current interest that represent a conceptual advance in the field.

NeuroToxicology specializes in publishing the best peer-reviewed original research papers dealing with the effects of toxic substances on the nervous system of humans and experimental animals of all ages. The Journal emphasizes papers dealing with the neurotoxic effects of environmentally significant chemical hazards, manufactured drugs and naturally occurring compounds. Papers dealing with the effects of neurotoxicants on other systems (e.g. reproductive, endocrine, immune) or processes (e.g. metabolic) are also welcome.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Neuropharmacology publishes high quality, original research and review articles within the discipline of neuroscience, especially articles with a neuropharmacological component. However, papers within any area of neuroscience will be considered. The journal does not usually accept clinical research, although preclinical neuropharmacological studies in humans may be considered. The journal only considers submissions in which the chemical structures and compositions of experimental agents are readily available in the literature or disclosed by the authors in the submitted manuscript. Only in exceptional circumstances will natural products be considered, and then only if the preparation is well defined by scientific means. Neuropharmacology publishes articles of any length (original research and reviews).Neuropharmacology also publishes succinct topical reviews on subjects within its remit. These reviews (of between 3000 and 5000 words) are commissioned by the Editorial Team or arise after correspondence with potential authors. Unsolicited reviews will be considered, but authors are encouraged to contact the Editor-in-Chief ahead of time of their intention to submit a review and to indicate clearly how the review differs from, and adds to, recent published reviews on related topics. On the basis of the case made by authors, potential overlap with planned Neuropharmacology content, and discussions with the Editorial Team, the Editor-in-Chief will provide authors with a decision regarding their proposed review as quickly as possible.The scope of the journal is broad. It covers many disciplines and spans molecules (e.g., molecular biology, biochemistry) through systems (e.g., neurophysiology) to behaviour (e.g. cognition, psychopharmacology). The journal covers all aspects of neuroscience with an emphasis on neurotransmitters and their receptors, ion channels, signalling, psychcopharmacology and animal models of disease, such as investigations on the neurobiology of cognition, depression, schizophrenia, anxiety, epilepsy, ischaemia, neuroprotection, neurodegeneration, drugs of abuse and pain.The journal publishes occasional Special Issues (and will consider publishing Supplements). Each year Elsevier/Neuropharmacology organise a satellite symposium to the Meeting of the Society for Neuroscience. The journal publishes a Special Issue to accompany each meeting. Please see http://www.neuropharmacology-conference.elsevier.com/ for details of this year's meeting and accompanying Special Issue.US National Institutes of Health (NIH) voluntary posting ("Public Access") policyNeuropharmacology and Elsevier facilitate the author's response to the NIH Public Access Policy. For more details please see the Guide for authors

Neuropsychopharmacology is an international scientific journal and the official publication of the American College of Neuropsychopharmacology (ACNP). This journal focuses upon clinical and basic science contributions that advance our understanding of the brain and behaviour, especially as related to the molecular, cellular, physiological and psychological properties of agents acting within the central nervous system and the identification of the new molecular targets for the development of the next generation of drugs. While original reports are preferred, mini-reviews and perspectives are invited by the editorial office. In view of the interdisciplinary nature of the field, particular emphasis is placed on:* studies that advance the biological bases of normal and pathological behavior* the nature, etiology and pathophysiology of neuropsychiatric disorders* biologically relevant aspects of the epidemiology, diagnosis, and treatment of these disorders* and the basic mechanisms by which psychopharmacological agents exert their effect.

Neurotherapeutics® is the journal of the American Society for Experimental NeuroTherapeutics (ASENT). Each issue provides critical reviews of an important topic relating to the treatment of neurological disorders, written by international authorities.  The Journal also includes original research articles in translational neuroscience including descriptions of cutting edge therapies that cross disciplinary lines and represent important contributions to neurotherapeutics for medical practitioners and other researchers in the field. Neurotherapeutics ® delivers a multidisciplinary perspective on the frontiers of translational neuroscience, provides perspectives on current research and practice, and covers social and ethical as well as scientific issues. Future Issue ThemesJanuary 2013 - Multiple Sclerosis
Guest Editor: Rohit Bakshi (BWH/Harvard)April 2013 - Mitochondrial Mechanisms in Neurologic Disease
Guest Editor: Andrea Gropman (Children’s National Medical Center) July 2013 - Protein Misfoldi

The official journal of the Neurotoxicity Society.Neurotoxicity Research is an international, interdisciplinary broad-based journal that contains papers reporting on both basic and clinical research on classical neurotoxins and mechanisms associated with neurodegeneration, apoptosis, nerve regeneration and neurotrophic actions.

Neurotoxicology and Teratology provides a forum for publishing new information regarding the effects of chemical and physical agents on the developing, adult or aging nervous system. In this context, the fields of neurotoxicology and teratology include studies of agent-induced alterations of nervous system function, with a focus on behavioral outcomes and their underlying physiological and neurochemical mechanisms. The Journal publishes original, peer-reviewed Research Reports of experimental, clinical, and epidemiological studies that address the neurotoxicity and/or functional teratology of pesticides, solvents, heavy metals, nanomaterials, organometals, industrial compounds, mixtures, drugs of abuse, pharmaceuticals, animal and plant toxins, atmospheric reaction products, and physical agents such as radiation and noise. These reports include traditional mammalian neurotoxicology experiments, human studies, studies using non-mammalian animal models, and mechanistic studies in vivo or in vitro. Special Issues, Reviews, Commentaries, Meeting Reports, and Symposium Papers provide timely updates on areas that have reached a critical point of synthesis, on aspects of a scientific field undergoing rapid change, or on areas that present special methodological or interpretive problems. Theoretical Articles address concepts and potential mechanisms underlying actions of agents of interest in the nervous system. The Journal also publishes Brief Communications that concisely describe a new method, technique, apparatus, or experimental result.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services .Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

NJC (New Journal of Chemistry) is a broad-based primary journal encompassing all branches of chemistry and its sub-disciplines. It publishes high-quality work that opens new directions in chemistry or in other scientific disciplines. Research must demonstrate that it will have an impact on areas of research other than that of the reported work.